Immune effector cells in SpA: What are the pathways?
Main Authors: | Bowness, P, Ridley, A, Chen, L, Shi, H, Zaarour, N, Yager, N, Simone, D, Hammitzsch, A, Al-Mossawi, M |
---|---|
Format: | Conference item |
Published: |
Clinical and Experimental Rheumatology
2018
|
Similar Items
-
The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis
by: Al-Mossawi, M, et al.
Published: (2013) -
The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.
by: Al-Mossawi, M, et al.
Published: (2013) -
BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
by: Hammitzsch, A, et al.
Published: (2014) -
The link between HLA-B27 and SpA--new ideas on an old problem.
by: McHugh, K, et al.
Published: (2012) -
Lessons from epigenetics for SpA
by: Knight, J
Published: (2018)